AtriCure, Inc.

AtriCure, Inc. develops and markets precise surgical devices, which create precise lesions used in cardiac and other soft tissue.  Founded in 2000 by a group of medical device specialists, the company has since succeeded in creating a greatly enhanced ablation technology for the treatment of atrial fribulation (AF).  AF is a condition where erratic electronic signals to the heart cause the upper two chambers to quiver rather than beat effectively.  More than 2.5 million Americans are afflicted by AF each year, a condition which makes them five-times more likely to experience a stroke.

---You can read the FULL article when you register (registration is free!) or sign-in to SmallCapInvestor.com---